AI Article Synopsis
- A study conducted in France updated the epidemiology of perioperative anaphylaxis, a rare but serious allergic reaction occurring during surgeries, highlighting its changing nature influenced by clinical practices and environment.* -
- Out of 765 cases analyzed, a significant portion (56%) were severe reactions, mainly caused by neuromuscular blocking agents (60%), with antibiotics like cefazolin also being a notable trigger.* -
- The study emphasizes the need for ongoing surveillance of perioperative anaphylaxis, particularly due to the increasing frequency of reactions to antibiotics and the unknown reasons behind cefazolin sensitization.*
Article Abstract
Background: Perioperative anaphylaxis is rare but is associated with significant morbidity. This complication has been well described in France by the GERAP (Groupe d'Etude des Réactions Anaphylactiques Périopératoires), a network focused on its study. The epidemiology of perioperative anaphylaxis is evolving, influenced by environmental factors and clinical practice. The aim of this study was to update the epidemiology of perioperative anaphylaxis in France.
Methods: This multicentre retrospective study was performed in 26 allergy clinics of the GERAP network in 2017-8.
Results: There were 765 patients with perioperative anaphylaxis included. Most cases were severe, with 428 (56%) reactions graded as 3 or 4 according to the Ring and Messmer classification. Skin test results were available for 676 patients, with a culprit agent identified in 471 cases (70%). Neuromuscular blocking agents were the main cause of perioperative anaphylaxis (n=281; 60%), followed by antibiotics (n=118; 25%) and patent blue dye (n=11; 2%). Cefazolin was the main antibiotic responsible for perioperative anaphylaxis (52% of antibiotic-related reactions). Suxamethonium and rocuronium were the main neuromuscular blocking agents responsible for perioperative anaphylaxis with 7.1 (6.1-8.4) and 5.6 (4.2-7.4) reactions per 100,000 vials sold, respectively, whereas cefazolin-related cases were estimated at 0.7 (0.5-0.9) reactions per 100,000 vials sold.
Conclusions: Our results confirm that most commonly identified triggering agents remain neuromuscular blocking agents. Reactions to antibiotics, particularly cefazolin, are becoming increasingly frequent. The origin of sensitisation to cefazolin is unknown, as no cross-sensitisation has been described, and it should be the subject of further study. Perioperative anaphylaxis should be followed over the years and understood given the changing triggers.
Clinical Trial Registration: ClinicalTrials.gov (NCT04654923).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11130666 | PMC |
| http://dx.doi.org/10.1016/j.bja.2024.01.044 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Perioperative anaphylaxis manifesting as cardiac arrest during cardiac surgery.
Allergy Asthma Proc
January 2025
Perioperative anaphylaxis is a serious entity with high morbidity and mortality. Perioperative anaphylaxis can be caused by any of the multitude of medications and substances used in anesthesia and surgery, and the most common causes include neuromuscular blocking agents, antibiotics, antiseptics, latex, and dyes. The differential diagnosis of perioperative anaphylaxis is wide from both an immunologic and a nonimmunologic standpoint.
View Article and Find Full Text PDFPerioperative anaphylaxis associated with peripheral inserted central catheter: A retrospective observational study.
J Vasc Access
December 2024
Department of Catheter Clinic, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China.
Article Synopsis
- - The use of Peripheral Inserted Central Catheters (PICC) for long-term intravenous therapy is rising, but there’s an alarming increase in anaphylaxis cases linked to this procedure.
- - A study at Sun Yat-sen University Cancer Center from January 2021 to August 2023 found that 0.10% of cancer patients experienced anaphylactic reactions during PICC placement, typically lasting around 8 minutes.
- - There is a call for heightened awareness and research among healthcare providers to identify what triggers these reactions and to develop better prevention strategies.
Evaluation of cephalosporin allergy: Survey of drug allergy experts.
J Allergy Clin Immunol Glob
February 2025
Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
Background: Since the publication of the 2022 Drug Allergy Practice Parameters (DAPP) of the American Academy of Allergy, Asthma & Immunology (AAAAI) and American College of Allergy, Asthma & Immunology (ACAAI), it is unclear the extent to which the simplified and risk-stratified evaluation of cephalosporin allergy has been incorporated into allergy practice.
Objective: We aimed to assess current cephalosporin allergy testing practices using real case examples.
Methods: An 18-question REDCap survey was sent to the 136 members of the Adverse Reactions to Drugs, Biologics and Latex (ARDBL) Committee of the AAAAI between February and April 2023.
Anaphylaxis induced by indocyanine green during abdominal surgery: A case report.
Saudi J Anaesth
October 2024
Department of Anesthesiology, University of Tsukuba Hospital, Tsukuba, Japan.
Since 2011, indocyanine green (ICG) has been increasingly used in surgery as a diagnostic tool. Although allergic reactions to this fluorescent dye are considered rare, they can result in anaphylactic shock. We report the case of a 33-year-old woman who developed anaphylaxis immediately after ICG administration during laparoscopic-assisted high anterior resection.
View Article and Find Full Text PDFEvaluation of immediate vancomycin-induced hypersensitivity reaction to severe perioperative anaphylaxis.
J Allergy Clin Immunol Glob
February 2025
Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.
The evaluation of vancomycin hypersensitivity reactions is challenging, as skin testing is not validated. Intradermal testing with vancomycin in human serum albumin-based sterile saline could be a new approach to the evaluation of IgE-independent hypersensitivity reactions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!